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Monitoring SARS-CoV-2 in wastewater during
New York City's second wave of COVID-19:
sewershed-level trends and relationships to
publicly available clinical testing data†
Catherine Hoar, a Francoise Chauvin,b Alexander Clare,b Hope McGibbon,b
Esmeraldo Castro,b Samantha Patinella,b Dimitrios Katehis,b John J. Dennehy,
Monica Trujillo,e Davida S. Smyth‡f and Andrea I. Silverman *a

cd

New York City's wastewater monitoring program tracked trends in sewershed-level SARS-CoV-2 loads
starting in the fall of 2020, just before the start of the city's second wave of the COVID-19 outbreak. During
a five-month study period, from November 8, 2020 to April 11, 2021, viral loads in influent wastewater from
each of New York City's 14 wastewater treatment plants were measured and compared to new laboratoryconfirmed COVID-19 cases for the populations in each corresponding sewershed, estimated from publicly
available clinical testing data. We found significant positive correlations between viral loads in wastewater
and new COVID-19 cases. The strength of the correlations varied depending on the sewershed, with
Spearman's rank correlation coefficients ranging between 0.38 and 0.81 (mean = 0.55). Based on a linear
regression analysis of a combined data set for New York City, we found that a 1 log10 change in the SARSCoV-2 viral load in wastewater corresponded to a 0.6 log10 change in the number of new laboratoryReceived 13th October 2021,
Accepted 5th March 2022

confirmed COVID-19 cases per day in a sewershed. An estimated minimum detectable case rate between
2–8 cases per day/100 000 people was associated with the method limit of detection in wastewater. This
work offers a preliminary assessment of the relationship between wastewater monitoring data and clinical

DOI: 10.1039/d1ew00747e

testing data in New York City. While routine monitoring and method optimization continue, information on
the development of New York City's wastewater monitoring program may provide insights for similar

rsc.li/es-water

wastewater-based epidemiology efforts in the future.

Water impact
Expanding the use of wastewater-based epidemiology (WBE) to inform public health responses requires an understanding of its performance across various
communities. Results from New York City's SARS-CoV-2 wastewater monitoring program indicate associations between wastewater data and clinical data in
a large urban setting and provide insights for the development of long-term WBE monitoring efforts.
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In March 2020, New York City became an epicenter of the coronavirus disease 2019 (COVID-19) pandemic. In response to this
first wave of COVID-19 cases, the New York City Department of
Environmental Protection (NYC DEP) – the city agency responsible for wastewater collection and treatment – launched a wastewater monitoring program with the goal of tracking sewershedlevel trends in the concentration of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes
COVID-19. The program was developed in partnership with researchers at New York University, Queens College,
Queensborough Community College, and The New School, with
all routine analysis conducted in the NYC DEP's existing microbiology laboratory under the management of the NYC DEP.
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Wastewater-based epidemiology (WBE) programs for
COVID-19, including the one in New York City (NYC), were
established on the premise that SARS-CoV-2 virions are excreted in the human waste of individuals infected with
SARS-CoV-2 and that the resulting concentrations of viral
RNA measured in wastewater are indicative of disease incidence or prevalence in the contributing sewershed. Significant associations between SARS-CoV-2 RNA concentrations
measured in wastewater and metrics of COVID-19 disease
incidence–including case rates–have been shown at scales
ranging from single buildings to entire sewersheds.1–3 Early
reports from WBE programs suggested promising applications that could help inform COVID-19 response measures,2,4 sparking widespread interest in SARS-CoV-2 monitoring programs around the world.5,6 While the extent to
which wastewater data is a leading indicator of trends in
COVID-19 incidence ahead of clinical data may vary depending on clinical testing rates,7,8 WBE data do offer the advantage of providing information representative of entire populations, free from clinical testing-related biases. In NYC,
where communities of color and high-poverty areas were
disproportionately impacted by the first wave of the COVID19 pandemic,9 testing rates varied spatially, with significant
demographic-based disparities.10 In situations where clinical
testing does not adequately sample vulnerable populations,
WBE may help inform modifications to testing strategies
and provide supplemental information regarding COVID-19
trends. Wastewater monitoring is therefore a potential tool
to identify new outbreaks of COVID-19 after high clinical
testing rates associated with major “waves” of disease incidence have subsided or when resources and technical capacity for extensive clinical testing of individuals are
limited.
These opportunities make WBE an attractive option for
many municipalities, including NYC, to confirm findings
from clinical testing about population-level COVID-19 dynamics and to monitor for new outbreaks in instances when testing is inadequate. In August 2020, the NYC DEP's SARS-CoV-2
wastewater monitoring program began routine analysis of influent wastewater collected from NYC's 14 wastewater treatment plants (referred to as wastewater resource recovery facilities (WRRFs) by the NYC DEP) (ESI† Table S1), capturing
data during the region's second wave of COVID-19 cases,
which started in the fall of 2020. The sewershed catchment
areas contributing to each of the 14 WRRFs vary markedly in
size, serving populations ranging from approximately 120 000
to 1.2 million residents. To assess the relationship between
NYC sewershed-level SARS-CoV-2 RNA concentrations and
confirmed cases of COVID-19 within each sewershed, wastewater data were compared to publicly available case data provided by the NYC Department of Health and Mental Hygiene
(DOHMH). In presenting findings from the NYC DEP, we also
aim to provide insights into the development of a wastewater
monitoring program designed for long-term, routine tracking
of trends in virus loads for multiple sewersheds serving a
large urban population.
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Methods
Sample collection and processing
24 h flow-weighted composite influent wastewater samples
were collected from each of NYC's 14 WRRFs twice weekly beginning August 31, 2020. From January 31, 2021 to April 18,
2021 sampling was reduced to once weekly. Each composite
sample consisted of eight grab samples collected every three
hours beginning at 7:00 AM on the sampling date. The volume of each grab sample added to the composite was determined based on the flowrate during the associated 3 h collection period. Samples were transported on ice and stored at 4
°C until processing, which started within twelve hours after
the final grab sample was collected. For each sampling date,
one of the 14 samples was analyzed in duplicate and the remainder were analyzed as single samples; facilities were selected for duplicate analysis on a rotating basis. A method
blank containing type I deionized water was included with
each set of samples to confirm the absence of contamination
during sample processing. Detailed descriptions of materials,
methods, and data analysis are provided in the ESI.† In brief,
40 mL aliquots of the 24 h composite samples were first pasteurized (60 °C, 90 min), and then centrifuged (5000 × g, 4
°C, 10 min) to remove solids. The supernatant was filtered
(0.22 μm, cellulose acetate) and then subjected to virus concentration using polyethylene glycol (PEG) precipitation (addition of 4.0 g PEG and 0.9 g NaCl followed by overnight incubation at 4 °C, and centrifugation at 12000 × g at 4 °C for
120 min to pellet viruses).11 The supernatant was discarded
and RNA (along with any DNA present) was extracted from
the concentrated PEG pellet using the Qiagen QiaAmp Viral
RNA Mini Kit with modifications (described in the ESI†).
SARS-CoV-2 quantification by RT-qPCR
A one-step RT-qPCR assay was used to quantify copies of the
SARS-CoV-2 nucleocapsid (N) gene, targeting the N1 region
(CDC RUO Primers and Probes, Integrated DNA Technologies)12 in triplicate reactions on a StepOnePlus real-time PCR
system (Thermo Fisher Scientific). Synthetic SARS-CoV-2 RNA
covering >99.9% of the viral genome (Twist Bioscience Control 1, GENBANK ID MT007544.1), quantified using reverse
transcription droplet digital PCR (RT-ddPCR) as described by
Al-Duroobi et al.,13 with a minor modification (details are
provided in the ESI†), served as both a positive control and
standard used in a decimal serial dilution for quantification
of N1 gene copies.
The limit of detection (LOD) and limit of quantification
(LOQ) for the assay were estimated from replicate standard
curves as described by Forootan et al. 2017 (ref. 14) and found
to be 180 copies per L of wastewater sample and 590 copies
per L of wastewater sample, respectively. We elected to use a
pooled standard curve to quantify samples on all plates to
ameliorate variability in standard preparation by different analysts from plate to plate. A description of the analysis used to
motivate this decision is presented in the ESI† (Fig. S1). The
absence of contamination during RT-qPCR preparation was
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confirmed through no template controls included on all RTqPCR plates. Only samples quantified above the LOQ were included in subsequent analysis. From September 8, 2020 to
June 8, 2021, samples were collected from each facility on 72
sampling dates, with samples from only two dates associated
with method blanks having N1 concentrations above the
LOD; samples collected on these two dates were flagged as
contaminated and were not included in subsequent analysis.
An attenuated bovine coronavirus (BCoV) (Calf-Guard® Bovine Rota-Coronavirus Vaccine, Zoetis) was used as a process
control.15,16 BCoV was inoculated into samples after the pasteurization step (details provided in the ESI†). A one-step RTqPCR assay, adapted from previously published assays,15–17
targeting the transmembrane-protein gene of BCoV was used
to qualitatively assess BCoV recovery for each sample using
an aliquot of the extracted RNA (primers and probes purchased from Integrated DNA Technologies). Detection of
BCoV was used to confirm whether viruses were recovered in
samples for which the N1 target was not detected. Additional
details regarding the RT-qPCR assays, standard curves, and
QA/QC procedures are provided in the ESI.†
Data analysis
The concentration of the N1 RNA target in wastewater (CWW)
was determined for each sample in units of N1 gene copies
(GC) per L according to eqn (1), where Nr is the number of
N1 GC measured by RT-qPCR, VRNA,s is the volume of RNA extracted from each sample (60 μL), VRNA,r is the volume of
template RNA added to the RT-qPCR reaction (5 μL), and Vs
is the volume of wastewater sample analyzed (0.04 L).
CWW = (Nr × VRNA,s)/(VRNA,r × Vs)

(1)

The resulting CWW was then normalized by the associated
daily influent wastewater flow rate (i.e., the flow rate in the
same facility on the same day) to calculate the SARS-CoV-2 viral loading rate (LWW) in units of N1 GC per day (eqn (2)).
Given that 60% of the NYC sewer system is a combined
stormwater–sewer system, flow-based normalization was used
to account for differences in per capita water usage and variability in wastewater flow rates caused by non-domestic water
inputs (e.g., rain events), which can affect measured virus
concentrations. In eqn (2), Q is the daily flow rate at the facility in millions of gallons per day (MGD), and CF is the conversion factor required to convert from liters to million gallons (3.78541 × 106 L MG−1). Continuous measurements of
flow rate were conducted at each facility using either magnetic flow meters or flow measuring weirs (with uncertainty
in measurements of ∼5%). Average daily flow rates had been
measured at each facility prior to the establishment of the
SARS-CoV-2 monitoring program, and thus required no additional analysis burden, making it a logistically advantageous
option for normalization of virus measurements.
LWW = CWW × Q × CF

This journal is © The Royal Society of Chemistry 2022
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Statistical analyses of relationships between SARS-CoV-2
loads in wastewater and laboratory-confirmed COVID-19
cases
Relationships between SARS-CoV-2 wastewater data in each
sewershed and laboratory-confirmed COVID-19 cases for the
associated sewershed population were evaluated through correlation and linear regression analyses. Clinical data were obtained from publicly available data provided by the NYC
DOHMH.18 In particular, the data set “last7days-by-modzcta.
csv”, which was posted online daily, was used to obtain daily
reports of the cumulative clinical molecular testing results
over the previous seven days for each modified ZIP code tabulation area (MODZCTA) in NYC.18 Specifically, data on the total clinical COVID-19 tests administered and the total number of positive tests (not including individuals who previously
tested positive), reported based on date of specimen collection, were obtained. Note that molecular tests included diagnostic PCR tests and did not include antigen or antibody
tests. This data set was used to calculate 7-day averages of
new COVID-19 cases (i.e., positive molecular tests) per day,
organized by the last date in the 7-day range. For example,
the 7-day average reported on February 14 represents the
daily average of new cases calculated based on the total number of positive molecular tests collected from February 8 to
February 14. Data were available starting on November 7,
2020, with data from March 15, 2021 to March 21, 2021 omitted due to technical issues related to data transmission during this period (Fig. S2†). While alternative data sets were
available with cumulative new COVID-19 case counts prior to
November 2020, these data were organized by the date that
test results were reported, as opposed to date of specimen
collection, and were therefore not recommended by NYC
DOHMH for use in calculating the number of daily new
COVID-19 cases.18
Each of the 177 MODZCTAs were assigned to one of NYC's
14 sewersheds. Of the 177 MODZCTAs, 44 straddled multiple
sewershed areas and were assigned to only the sewershed in
which it had the greatest overlapping land area, determined
based on visual inspection of sewershed boundary maps provided by the NYC DEP Bureau of Water and Sewer Operations. Total new cases in each sewershed for each 7-day period were calculated by summing the cumulative 7-day
positive test counts in each MODZCTA assigned to that
sewershed. The same data set was used to calculate 7-day averages of COVID-19 testing rates (i.e., the number of tests administered divided by the total population) and the percentages of COVID-19 tests that were positive for each sewershed
(Fig. S2†).
Spearman correlations between SARS-CoV-2 viral loading
rates in wastewater (N1 GC per day) and 7-day averages of
new daily COVID-19 cases were determined for each individual sewershed for a five-month study period (November 8,
2020 to April 11, 2021). Correlations were also determined for
a combined data set that included each data pair (i.e., SARSCoV-2 viral loading rates and 7-day average of new COVID-19
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cases on each date) for all facilities, excluding the Port Richmond and Oakwood Beach WRRFs (see the Results and discussion section). For the combined data, correlations were
also evaluated after removing data pairs associated with potentially inadequate clinical testing rates: data for dates with
percentages of positive molecular tests (7-day average) that
exceeded 10% in the sewershed were excluded. A general
benchmark suggested by the World Health Organization in
the Spring of 2020 indicated that clinical testing is less likely
to represent all infections in a population when the percentage of positive tests exceeds approximately 10%;19,20 we therefore excluded these data in an effort to best approximate the
incidence of SARS-CoV-2 infections.
To assess whether trends in SARS-CoV-2 viral loading rates
in wastewater preceded trends in clinical testing data, correlations between the two data sets were also evaluated for each
sewershed with the clinical data shifted back in time with
lags ranging from −7 to 21 days. Additional details for this
analysis are provided in the ESI.†
Simple linear regressions were performed using log10transformed SARS-CoV-2 viral loading rates (N1 GC per day)
and log10-transformed 7-day averages of new COVID-19 cases
(new COVID-19 cases per day) for each individual sewershed.
For each sewershed, Spearman correlations were determined
between the slope of the resulting linear regression line and
the (1) average testing rate for the study period, (2) average
wastewater flow rate, (3) population, and (4) average per
capita wastewater flow rate. Linear regressions were also performed using log10-transformed SARS-CoV-2 viral loading
rates (N1 GC per day) and log10-transformed 7-day averages of
new COVID-19 cases (new COVID-19 cases per day) for the
combined data set, both with and without the testing rate filter described above. Linear regressions were used to estimate
the equivalent number of cases per day/100 000 people associated with the method LOD (CLOD), equal to 180 N1 GC L−1.
This estimate was calculated for each facility using individual, sewershed-specific linear regressions and using the linear regression for the combined data set. First, the LOD was
converted to a SARS-CoV-2 viral loading rate in wastewater
(LWW,LOD) for each sewershed in units of N1 GC per day using
eqn (3), where Qavg is the average of daily flow rates at the facility over the study period (Table S1†), in MGD.
LWW,LOD = CLOD × Qavg × CF

(3)

LWW,LOD for each sewershed were then input to the linear regressions determined for each sewershed to estimate the
number of new COVID-19 cases per day associated with the
SARS-CoV-2 method LOD (CaseLOD), using eqn (4), where m
and b are the slope and y-intercept of the linear regression
line, respectively (presented for each sewershed in the Results
and discussion section). An example estimation is illustrated
graphically in Fig. S6.† Resulting CaseLOD values were normalized per 100 000 people using MODZCTA-level population estimates from the NYC DOHMH NYC Coronavirus Disease
2019 (COVID-19) data.18

1024 | Environ. Sci.: Water Res. Technol., 2022, 8, 1021–1035

log10(CaseLOD) = m × log10(LWW,LOD) + b

(4)

Statistical analyses were performed using R, and figures were
created using GraphPad Prism.21,22

Results and discussion
Methodological considerations for SARS-CoV-2 quantification
in wastewater
The public health emergency caused by the emergence of
COVID-19 required the expedited development of NYC DEP's
SARS-CoV-2 wastewater monitoring program. As such, several
methodological choices for virus quantification were considered, and the ultimate standard operating procedure (SOP)
described herein was developed reflecting NYC DEP's program goals of monitoring trends in SARS-CoV-2 viral loads in
wastewater, accounting for equipment availability, existing
expertise of personnel, and considerations of material procurement. Selections were also made to minimize analystbased variability. For example, commercially-available kits for
RNA extraction were considered over alternatives that may be
more sensitive to analyst skill and consistency. Data analysis
and internally-developed QA/QC guidelines were established
in line with programmatic goals. Additional methodological
considerations, such as the inclusion of a filtration step in
sample preparation, are discussed in the ESI.†
Long-term routine monitoring to assess virus trends through
quantification with RT-qPCR requires reliable comparison of
data originating from different RT-qPCR plates prepared by different analysts, which presents several challenges. First, this
program relied on the use of a synthetic RNA control as a standard for the N1 RNA target. Because the concentration of this
RNA control was found to differ between lots purchased at different times, one lot of the RNA control was quantified using
RT-ddPCR13 (details are provided in the ESI†). We then determined the concentration of all other RNA control lots relative to
this quantified lot. In addition, standard curves for routine RTqPCR assays were prepared by different analysts on different
days, with separate serial dilutions of standards performed for
each individual RT-qPCR plate. To account for any resulting variability caused by these aspects of the RT-qPCR quantification
method and allow comparison of measured concentrations over
the course of many months, we applied a pooled standard curve
for quantification of all samples (Fig. S1†). Challenges associated with RT-qPCR-based quantification using a standard curve
highlight the benefits of alternative methods, such as digital
PCR for absolute RNA quantification, which eliminates the need
for a standard curve and may offer more sensitive detection for
environmental samples.23 Nonetheless, the methodology employed in this work allowed us to compare relative viral loads
and confidently assess of trends of SARS-CoV-2 in wastewater
over time.
SARS-CoV-2 viral loads in influent wastewater
SARS-CoV-2 viral loads in NYC's 14 sewersheds between September 8, 2020 and June 8, 2021 were determined from

This journal is © The Royal Society of Chemistry 2022
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quantifiable N1 gene copy (GC) concentrations in influent
samples and are presented normalized by sewershed population (Table S1† (ref. 24)) in Fig. 1. Maximum populationnormalized SARS-CoV-2 viral loads for each facility during
this period ranged from 6.2 × 106 to 2.7 × 107 N1 GC per day/
population, with many of these values occurring around the
time when a peak in COVID-19 cases was observed (January
2021). Note that in September of 2020, prior to the increase
in COVID-19 cases associated with NYC's second wave of the
outbreak, N1 concentrations in wastewater remained below
the LOQ in several sewersheds.

Paper
Visual inspection of trends in SARS-CoV-2 quantities in
wastewater and new laboratory-confirmed COVID-19 cases indicates an association between the wastewater and clinical
data. The strength of this association varied across
sewersheds, as reflected in results from statistical analysis
presented in the next section. Additionally, most sewersheds
exhibited peaks for both data sets in January 2021 (Fig. 1),
with two notable exceptions being Oakwood Beach and Port
Richmond, discussed below. Sewersheds with lower incidence
rates (new cases per day/100 000 people) of COVID-19 (e.g.,
Red Hook WRRF) generally had lower per capita SARS-CoV-2

Fig. 1 Summary of SARS-CoV-2 wastewater data for New York City's 14 sewersheds. Data from September 8, 2020 to June 8, 2021 is shown, with
the period for which statistical analysis was conducted (November 8, 2020 to April 11, 2021) bounded by vertical dotted lines. Primary (left) y-axis,
blue circles: influent SARS-CoV-2 viral loads normalized by sewershed populations. Error bars indicate standard deviations from triplicate RT-qPCR
reactions as well as standard deviations of duplicate samples, where applicable. Dashed black lines represent LOESS curve fits (span = 0.4), with
the 95% confidence intervals shaded in grey. Secondary (right) y-axis, red line: 7-day average of new COVID-19 cases per day/100 000 people in
the previous 7 days normalized using MODZCTA-level population estimates from the NYC DOHMH's NYC Coronavirus Disease 2019 (COVID-19)
data.18 Normalization by population was used for visual comparison across different sewersheds only and was not used for statistical analysis. Note
that Newtown Creek WRRF also serves a small section of Queens.

This journal is © The Royal Society of Chemistry 2022
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viral loads in wastewater than those with higher incidence
rates of COVID-19 (e.g., Hunts Point WRRF).
SARS-CoV-2 viral loads in the Coney Island WRRF influent
in September 2020 and October 2020 displayed a high degree
of variability, with some measured virus loads that were
greater than those in all other sewersheds during that period,
despite a consistent processing method applied for all samples and confirmed COVID-19 case rates that were consistently low across NYC (Fig. 1). While there were relatively low
rates of clinical testing in New York City in September 2020
and COVID-19 clusters emerged in some neighborhoods
served by the Coney Island WRRF at that time,25 it is unclear
if these factors contributed to the high viral loads measured
in some Coney Island WRRF samples. For example, COVID19 clusters were also identified in other sewersheds at this
time, yet did not result in high SARS-CoV-2 loads in influent
samples collected from other WRRFs, and it is difficult to determine whether clinical testing was adequate. It should also
be noted that given its large geographic resolution,
sewershed-level monitoring may not fully capture the effect
of disease clusters (such as those identified at high spatiotemporal resolution using clinical data26) that may be relatively small compared to the sewershed or may straddle multiple sewersheds.
A smaller extent of variability in measured SARS-CoV-2 viral loads was observed to varying degrees across all facilities
and can stem from several sources. Evaluation of duplicate
samples analyzed during the study period allowed for an assessment of potential variability due to sample processing
and RNA quantification. Relative standard deviations for N1
concentrations of duplicate samples (i.e., the standard deviation of concentrations from duplicate samples, each with
triplicate RT-qPCR reactions, as a percent of the average concentration) ranged from 3% to 44% (mean = 18%, median =
14%); these values are comparable to those reported elsewhere for measurement of N1 concentrations in influent
wastewater.16,27 Aside from methodological sources of variability, additional sources of variability or uncertainty could
include (1) dilution of wastewater from non-domestic water
inputs and variations in domestic water use habits, (2) wastewater chemical composition, which may interfere with sample processing or RNA quantification methods, (3) variability
in SARS-CoV-2 shedding intensity and duration for infected
individuals28–30 and (4) the extent and consistency of viral
RNA degradation in sewers.27,31
To account for variability in wastewater flow rates and
minimize the effect of (1), viral loads calculated using measured wastewater flow rates (eqn (2)) were used for analysis
instead of N1 concentrations. The impact of factor (2),
namely, RT-qPCR inhibition, was assessed by evaluating tenfold dilutions of a selection of samples from each WRRF; inhibition was considered minimal in the evaluated samples
based on comparison of Cq values between diluted samples
and associated undiluted samples (details provided in the
ESI†). Regular assessment of inhibition with control assays
was not feasible during routine monitoring due to resource

1026 | Environ. Sci.: Water Res. Technol., 2022, 8, 1021–1035

Environmental Science: Water Research & Technology
constraints. In addition, dilution of RNA, a strategy used to
reduce PCR inhibition, was avoided in order to maintain consistency in sample processing, given the risk of diluting samples to viral concentrations below the limits of quantification
or detection during periods with low COVID-19 case rates.
While beyond the scope of this work, assessment of viral recovery and wastewater matrix effects should be considered
for future research aiming to characterize uncertainty in
WBE data. For example, identifying and characterizing external factors related to (3) and (4) is the focus of ongoing SARSCoV-2 WBE research efforts. Considering these uncertainties
and variabilities in wastewater data, which likely increase
with scale,32 we did not attempt to quantify the number of
SARS-CoV-2 infections in each sewershed based on wastewater data, but instead explored the relationship between viral
quantities in wastewater and publicly available clinical data
to assess trends and associations, and examined differences
between sewersheds. Nonetheless, poorly characterized variability in WBE data can hamper the critical goal of relating
viral loads in wastewater to disease dynamics. Clear characterization of uncertainties related to analytical methodologies
would therefore facilitate interpretation of wastewater data by
public health agencies.33
As mentioned above, SARS-CoV-2 viral loads in wastewater
from the Port Richmond and Oakwood Beach WRRFs (both
located in the borough of Staten Island) did not capture the
peak in COVID-19 cases that was observed in January 2021
across all sewersheds. In the Port Richmond and Oakwood
Beach sewersheds there was a marked increase in COVID-19
cases in December 2020 that was accompanied by an associated peak in the SARS-CoV-2 viral load in wastewater during
this time. However, as new COVID-19 cases in Staten Island
increased by 60% in January 2021, the virus loads in wastewater stayed constant or decreased. Compared to sewersheds in
the other boroughs, those in Staten Island had relatively high
clinical test positivity in December and January (7–14%), despite having an average testing rate (i.e., number of clinical
tests administered per capita) for the study period that was
greater than that of over half of the other sewersheds (Fig.
S2†). This observation suggests that testing may not have adequately captured all infections in Staten Island during this
period. While inadequate clinical testing rates could potentially reduce the accuracy of the observed relationships between clinical and wastewater data for these sewersheds, it
does not explain the lower-than-expected SARS-CoV-2 viral
loads measured in Staten Island wastewater in January 2020.
A more likely explanation could stem from the composition
or operation of the wastewater system in the borough. For example, a portion of the Staten Island population is not served
by the sewer system and instead uses septic systems. As such,
a segment of this population does not contribute to the sewer
system, and viruses excreted by these residents would not
have been present in the influent wastewater at the Oakwood
Beach and Port Richmond WRRFs. Nonetheless, given that
the population served by septic systems on Staten Island is
thought to be smaller than those served by the sewer system,
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it is unlikely that this hypothesis can entirely explain the discrepancy between measured SARS-CoV-2 viral loads and new
COVID-19 cases. In addition, much of Staten Island uses separated rather than combined stormwater–sewer systems,
which could potentially impact the wastewater matrix and influence viral recovery during concentration and quantification steps in sample analysis. Because of these discrepancies,
the Staten Island sewersheds were excluded from analysis of
the combined data set and the estimation of minimum
COVID-19 case rates associated with the LOD.

Relationships between SARS-CoV-2 viral loads in wastewater
and new laboratory-confirmed COVID-19 cases
The relationships between SARS-CoV-2 viral loads in wastewater and new laboratory-confirmed COVID-19 cases in the corresponding sewershed populations were assessed between
November 8, 2020 and April 11, 2021. By early June 2021,
city-wide weekly averages of the percentage of positive
COVID-19 clinical tests declined below l%, and over 50% of
NYC residents had received at least one dose of a COVID-19
vaccine.18,34 To minimize the potential impact of mass vaccination on the evaluation of relationships between case rates
and SARS-CoV-2 concentrations in wastewater presented in
this work, we chose to conduct the statistical analyses described below for a period ending in early April, shortly after
New York State extended vaccination availability to individuals of 16 years and older.
Significant positive correlations between SARS-CoV-2 viral
loads in wastewater and new laboratory-confirmed COVID-19
cases in the corresponding populations were found for all individual sewersheds and for a combined data set that included all sewersheds other than Port Richmond and
Oakwood Beach (Spearman, p < 0.05), indicating, as expected, that an increase in COVID-19 cases was associated
with an increase in SARS-CoV-2 concentrations in wastewater
(Fig. 2). Correlation coefficients (ρ) for the individual
sewersheds ranged from 0.38 (Coney Island WRRF) to 0.81
(Wards Island WRRF), with an average of 0.55 and a median
of 0.55; correlation coefficients for four sewersheds were
greater than or equal to 0.60. Similar correlation coefficients
between SARS-CoV-2 wastewater concentrations and clinical
case data have been reported elsewhere.16,35 Note that analysis of correlations between virus concentrations (N1 GC L−1,
as opposed to virus loads) and new COVID-19 case rates
(cases per day/100 000, as opposed to cases per day) yielded
similar results (Table S3†). The correlation coefficient for the
combined data set (ρ = 0.82) was higher than for any of the
individual sewersheds (Fig. 3a).
For each sewershed, minimal differences were observed
between the magnitudes of the Spearman's rank correlation
coefficients determined using data sets with and without lag
times applied (Fig. S4†). Some previous studies, applying a
variety of assessment methods, have suggested that there is a
time lag for the identification of clinical cases after the measurement of SARS-CoV-2 in wastewater that ranges on the or-
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der of days to weeks, while others have indicated that the
SARS-CoV-2 concentration in wastewater is not a leading indicator of COVID-19 diagnosis.8 Inconsistent findings for lag
times may be attributed to whether clinical data are presented (1) by the date of specimen collection, (2) by the date
that results are reported, or (3) as a rolling average of either
over multiple days, as well as the adequacy of COVID-19 testing rates, which vary in different regions and shift across
time. Clinical data collected during periods with low testing
rates are less likely to capture all infections in a region, and
individuals may be more likely to be tested after symptom
onset, at a time when viral shedding in feces may have already begun. These conditions can result in a lag behind
wastewater monitoring data, which provides viral load information independent from clinical testing rates. Data for this
work was collected during a time when testing rates were significantly higher than those during the first wave of the pandemic in NYC, and weekly median turnaround times for test
results were 1 to 2 days.18 In addition, we could not confidently rule out that the small improvements in correlations
observed when applying a lag time for some sewersheds was
an artifact of variability in the measured wastewater data.
Furthermore, our preliminary assessment of lag time did not
include analysis of autocorrelation, which could be considered in future work. A rigorous assessment of lag time would
need to account for contributions of previous as well as newly
infected individuals to viral loads in wastewater, which was
beyond the scope of this work. For these reasons, we compared data sets without a time lag for subsequent comparisons and linear regression analysis. It should also be noted
that reported observations regarding lag times may not apply
after mass vaccination or the spread of new viral variants, as
the potential effects of these factors on fecal shedding of
SARS-CoV-2 are currently unknown.
Because the nonparametric Spearman's rank correlation
was used for this analysis, results suggest that there is, at
minimum, a monotonic, direct relationship between SARSCoV-2 quantified in wastewater and clinically confirmed
COVID-19 cases. Linear relationships between the two log10transformed datasets were assessed through analysis of linear
regressions, with the best fit found for the Wards Island
WRRF (R 2 = 0.65) and some of the poorest fits found for the
sewersheds in Staten Island (Fig. 2). Inconsistent relationships between sewershed-level SARS-CoV-2 viral loads in
wastewater and COVID-19 cases observed across sewersheds
may be due to differences in the sewer systems for each
sewershed, including sewershed areas, residence times of
wastewater in the sewer system, the presence of nondomestic wastewater inputs, proportions of the population
made up by transient individuals or commuters, and per
capita water use. Differences could also be related to clinical
testing rates for each sewershed, though no significant correlation was found between the slopes of the linear regression
lines and the average testing rates for the study period for
each sewershed (Spearman, p > 0.05). Similarly, no significant correlations were found between the slopes of the linear
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Fig. 2 Linear regressions of log10-transformed SARS-CoV-2 viral loads in wastewater (N1 GC per day) and log10-transformed 7-day averages of
new COVID-19 cases per day for each sewershed in New York City. Linear regressions (solid lines) and associated 95% confidence intervals (dashed
lines) are shown along with goodness of fit R 2 values for those data sets with significantly non-zero slopes. Note that linear regression for Port
Richmond has been excluded as the slope was not significantly non-zero (see ESI†). The Spearman's rank correlation coefficient (ρ) between N1
GC per day and new COVID-19 cases per day is shown at the top of each sewershed plot, with significance levels indicated (*p < 0.05, **p < 0.01,
***p < 0.001, ****p < 0.0001).

1028 | Environ. Sci.: Water Res. Technol., 2022, 8, 1021–1035

This journal is © The Royal Society of Chemistry 2022

View Article Online

Open Access Article. Published on 16 March 2022. Downloaded on 9/5/2022 3:26:33 AM.
This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence.

Environmental Science: Water Research & Technology

Paper

Fig. 3 Linear regressions of log10-transformed flow-normalized SARS-CoV-2 viral loads in wastewater (N1 GC per day) and log10-transformed
7-day averages of new COVID-19 cases per day for (a) the combined data set, (b) data from the combined data set associated with a rise in cases,
and (c) data from the combined data set associated with a decline in cases. Data associated with potentially inadequate testing (i.e., over 10% positive tests) are not included in this analysis. Data from the Port Richmond and Oakwood Beach WRRFs have also been excluded. Linear regressions
(solid lines) and associated 95% confidence intervals (dashed lines) are shown along with goodness of fit R 2 values and Spearman's rank correlation
coefficients (ρ) between N1 GC per day and new COVID-19 cases per day.

regression lines for each sewershed and the (1) average wastewater flow rate, (2) sewershed population, or (3) average per
capita wastewater flow rate (Spearman, p > 0.05), which was
expected given that N1 concentrations were normalized by
flow rate. Nonetheless, the linear regression found between
log10-transformed SARS-CoV-2 viral loads in wastewater and
log10-transformed 7-day averages of new COVID-19 cases per
day using the combined data set had a strong fit (R 2 = 0.72)
relative to the fits of regressions for the individual
sewersheds.
Evaluations of the utility of SARS-CoV-2 wastewater monitoring data has largely involved comparison of viral RNA in
wastewater to COVID-19 case counts based on clinical testing.36 Given that the accuracy of confirmed case rates as a
measure of the number of infected individuals is dependent
on COVID-19 testing rates, this comparison must be made
with a consideration of clinical testing biases. Moreover, if
multiple clinical data types are available, one must determine
which is most appropriate for comparison to wastewater
data. The analysis applied herein utilized a data set containing 7-day averages of new COVID-19 cases based on testing in
each approximated sewershed area. Uncertainties surrounding such clinical testing data include (1) whether there were
regional biases in testing results (Fig. S2†), potentially due to
testing disparities;10 (2) whether testing rates were adequate

This journal is © The Royal Society of Chemistry 2022

and what constitutes adequate testing; and (3) how long before specimen collection infected individuals contracted
COVID-19 and started shedding the virus. Others have reported correlations of wastewater data with COVID-19 surveillance data sets other than clinical case rates, such as clinical
test positivity or hospitalization rates.2 Hospital admissions
data, although not without its own biases,37 may be an alternative epidemiological metric to compare to or to validate
wastewater monitoring data if significant inadequacies in
clinical testing are suspected, though the relationship between hospitalization data and wastewater data may differ
for vaccinated and unvaccinated populations. While hospitalization data at the MODZCTA level were not publicly available
for NYC, visual comparison at the borough level indicates
that trends in daily hospitalizations generally reflected trends
in case rates for sewersheds within each borough (Fig. S3†).
The limitations of clinical testing are in fact a major driver
for the application of WBE, which aims to provide
community-level information free from clinical testing
bias.38–40 Continued population-level monitoring from wastewater data could become increasingly useful in areas where
clinical testing rates decline or resources for clinical testing
are limited.
Linear regressions for the combined data set are presented in Fig. 3, with data collected on dates with over 10%
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positive COVID-19 testing rates removed. Removing data associated with potentially inadequate testing from the combined data set did not significantly change the regression
(analysis of covariance, p > 0.05) compared to the full data
set without filtering (Fig. S5†). After the peak in COVID-19
cases in NYC in January 2021, there was a decline in cases
across all sewersheds. The relationship between SARS-CoV-2
loads in wastewater and new clinical COVID-19 cases during
the period of declining cases (after January 2021) was not
found to be significantly different from the relationship during the period when cases were increasing (prior to January
2021), based on a comparison of separate linear regressions
for the data associated with the rise in case rates and the decline in case rates (analysis of covariance comparing slopes, p
> 0.05; Fig. 3b and c).
The slope of the linear regression line for the full combined
data set was found to be 0.6 (Fig. 3a), indicating that a 1 log10
change in the number of N1 GC per day corresponded to a 0.6
log10 change in the number of new laboratory-confirmed
COVID-19 cases per day in a sewershed. Metrics such as these
are derived from relative changes in viral load, and therefore
do not require absolute quantification of viral concentrations
in wastewater, allowing for comparison to other studies and alleviating challenges related to absolute quantification of standard curves. However, this metric comparing SARS-CoV-2
loads and daily new COVID-19 cases has not been consistently
reported in studies monitoring SARS-CoV-2 in influent wastewater. Harmonizing data analysis strategies to include such a
metric would improve efforts to compare results across different locations. The slope of 0.6 observed herein is greater than
that reported previously by Wolfe et al. (slope = 0.24), who
compared SARS-CoV-2 concentrations measured in primary
wastewater settled solids and COVID-19 incidence in seven
publicly owned treatment works located across the United
States, including one of the NYC facilities described in this
work.36 However, it is important to note that Wolfe et al. examined daily incident cases/population and primary settled solids
samples for SARS-CoV-2 concentrations, which differ from the
influent wastewater evaluated herein. In addition, Wolfe et al.
normalized measured SARS-CoV-2 concentrations in wastewater solids by concentrations of pepper mild mottle virus
(PMMoV),36 a normalization biomarker that has also been
used by others,16,41 rather than using influent flow rates to calculate viral loads. The differences in the slopes may be due to
either of these factors, to variations in the relationship between SARS-CoV-2 wastewater loads and COVID-19 cases in
different regions, or to a difference in the overall sensitivity of
the methodology applied by Wolfe et al.
At present, limitations regarding the accuracy of COVID-19
clinical testing data and uncertainties related to SARS-CoV-2
measurements in wastewater–including SARS-CoV-2 shedding
rates and RNA stability in different sewersheds–preclude development and validation of a universal, quantitative model
to predict disease incidence based on viral RNA concentrations in wastewater. Ongoing research continues to expand
our understanding of critical model parameters and factors
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contributing to uncertainty, owing particularly to SARS-CoV-2
monitoring work completed at smaller scales (e.g., buildinglevel),42 from which information about the contributing population can be obtained more easily than from larger
sewersheds. An attempt to quantify COVID-19 case rates in
NYC's sewersheds based on wastewater data at this time
would be inaccurate, and is not currently recommended for
application in the realm of public health.43 However, based
on our analysis and others, there is utility in using wastewater data to monitor trends in COVID-19 incidence.

Estimated case rates associated with method LOD
The utility of SARS-CoV-2 wastewater data depends on
whether virions are present in wastewater at detectable concentrations (i.e., above the LOD and LOQ). It is therefore useful to approximate the minimum number of contributing
COVID-19 cases per day required for detection of the SARSCoV-2 N1 gene target in wastewater using the methodology
described here. When estimated using individual, sewershedspecific linear regressions (Fig. 2), the minimum new COVID19 case rate that corresponds to the method LOD varied for
each sewershed, ranging between 2 and 8 cases per day/100
000 people (Table S4†). Minimum detectable case rates were
also estimated for each sewershed using the linear regression
from the combined data set and the average daily influent
flow rates for each WRRF during the study period. These estimates fell within the same range as those derived from
sewershed-specific linear regressions (Table S4†).
The minimum detectable case rate estimates presented
here should be taken as order-of-magnitude approximations
rather than absolute quantities, especially considering the
varying strength of the linear relationships between data for
certain sewersheds (e.g., data sets for Coney Island, Bowery
Bay, Oakwood Beach, and Port Richmond WRRFs had Pearson correlation coefficients below 0.5). Furthermore, these
findings hold only for the specific SARS-CoV-2 concentration,
RNA extraction, and RT-qPCR methodology applied herein
(as different methodologies will likely have different sensitivities and resulting LODs), and may not be transferable to locations with different per capita wastewater flow rates, even if
testing rates and case rates are similar to those described
here. The estimates may also be limited by the assumption
that the dominant source of the SARS-CoV-2 viral load in the
wastewater is from recent cases as opposed to prolonged fecal shedding, which is consistent with assumptions made in
previous studies.36,44 The relationships found are also limited
by the accuracy of clinical testing data, as discussed above.
Furthermore, variability in virus shedding rates were not considered for the simple linear models in our study. By April
2021, Iota (B.1.526) and Alpha (B.1.1.7) had become the dominant SARS-CoV-2 variants observed in NYC, based on data
summarizing the percent of sequenced clinical samples associated with each variant identified in NYC starting in January
2021.18 Delta (B.1.617.2) and Omicron (B.1.1.529) variants
were not present in notable numbers during the study
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period, based on the same data set.18 It is still unknown how
different SARS-CoV-2 variants affect fecal shedding rates of
the virus; therefore, it is possible that the relationships described herein may not be applicable during periods when
variants other than those present during the study period are
dominant.
As COVID-19 cases declined in NYC in the spring and
early summer of 2021, the estimated minimum detectable
COVID-19 case rates were reached in most sewersheds by
May and June 2021. As such, we expected that SARS-CoV-2 viral loads in wastewater would have decreased to below the
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LOQ and LOD at this time. However, viral RNA was still detectable in influent wastewater collected from all sewersheds
in mid June 2021 (Fig. 4). While this discrepancy may be explained by the limitations described above, it may also be
due to decreasing COVID-19 testing rates, which could result
in reduced diagnosis of individuals with asymptomatic infections, who are less likely to seek out COVID-19 tests. For example, the average COVID-19 testing rate in NYC during the
period from May 2, 2021 to June 8, 2021 (390 test per day/
100 000 people) decreased 30% from the average in January
2021 (560 tests per day/100 000 people). Additionally,

Fig. 4 SARS-CoV-2 wastewater data and COVID-19 case data from May 2, 2021 to June 8, 2021. The date on which the case rate first fell below
the estimated minimum detectable case rate (based on the sewershed-level linear regression) is indicated with a solid vertical line for each
sewershed. Shaded regions indicate the time period during which case rates were below the estimated minimum detectable case rate. Primary
(left) y-axis, blue circles: influent SARS-CoV-2 viral loads normalized by sewershed populations. Error bars indicate standard deviations from triplicate RT-qPCR reactions as well as standard deviations of duplicate samples, where applicable. Open circles represent N1 concentrations below
the limit of quantification (LOQ). Samples below the limit of detection (LOD, shown with a horizontal dotted line) are denoted with an “X”. Secondary (right) y-axis, red line: 7-day average of new COVID-19 cases per day/100 000 people in the previous 7 days. Estimated minimum detectable
case rates (new cases per day/100 000) needed to detect SARS-CoV-2 in wastewater, based on linear regressions derived from sewershed-level
data and the combined data set, are indicated with tick marks across the right y-axes.
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widespread vaccination of adults in New York may have resulted in asymptomatic and mild infections that were not diagnosed. While individuals with asymptomatic SARS-CoV-2
infections may not be captured by clinical testing, viral shedding by asymptomatic individuals would still contribute to
the viral load in wastewater, given that SARS-CoV-2 has been
detected in fecal samples associated with asymptomatic or
mild cases of COVID-19.45–47 Viral loads may have also been
elevated in wastewater because of prolonged fecal shedding
of the virus. Finally, it is possible that the linear relationship
found in this work does not hold at low SARS-CoV-2 infection
levels as the study period used for statistical analysis included only case rates above the minimum detectable case
rates estimated for each sewershed.
The estimated minimum numbers of COVID-19 cases required before SARS-CoV-2 can be detected in wastewater from
NYC sewersheds are associated with considerable disease incidence that may be captured if some degree of clinical testing continues. Nonetheless, these estimates could aid public
health agencies in understanding what COVID-19 incidence
to expect if SARS-CoV-2 loads measured in wastewater influent cross the threshold from being below the detection limit
to being detected. Improvements to analytical methods that
lower the LOD48–50 would expand the utility of WBE in indicating low levels of disease incidence.

Conclusion
Results presented herein demonstrate that relative trends in
SARS-CoV-2 loads in NYC wastewater can be evaluated and
associated with trends in clinical COVID-19 testing data, and
have potential to contribute to situational awareness of disease incidence in large urban sewersheds. SARS-CoV-2 loads
were strongly correlated with reported rates of new COVID-19
cases (Spearman's ρ = 0.82) based on a combined data set including 12 of NYC's 14 sewersheds during a study period that
included both the rise and decline of the City's second major
peak in COVID-19 cases. Ours is the first study to confirm a
direct, linear relationship between SARS-CoV-2 wastewater
data and clinical testing data for NYC, a finding consistent
with reports for other large urban areas. Our results indicate
that the relationship we found between SARS-CoV-2 loads
and COVID-19 cases held during both the rise and the decline in cases, under the conditions of the study period (e.g.,
rates of vaccination, proportions of dominant SARS-CoV-2
variants). Specifically, we found that a 1 log10 change in the
number of N1 GC per day corresponded to a 0.6 log10 change
in the number of new laboratory-confirmed COVID-19 cases
per day in a sewershed, a metric that provides qualitative insights into COVID-19 trends, even in the absence of absolute
quantification of SARS-CoV-2 viral loads.
The strengths of the correlations observed for each of
NYC's sewersheds differed (Spearman's ρ between 0.38 and
0.81), underscoring that the utility of wastewater monitoring
for estimating disease incidence may be localized and that
further research is critical to understanding and addressing
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this variability and uncertainty. Moreover, Iota and Alpha became the dominant SARS-CoV-2 variants observed in NYC by
the end of the study period; if different variants cause different fecal shedding rates of the virus, these findings may not
hold when variants such as Omicron, which was not dominant during the study period, are more prevalent in a contributing population.
Additionally, establishing the range of disease incidence
associated with the limit of detection for SARS-CoV-2—or any
WBE target—as we have done herein (e.g., 2–8 COVID-19
cases per day/100 000 people), may be useful for understanding the public health implications of initial detection of a target in wastewater. These values serve as order-of-magnitude
estimates and are dependent on the methodology applied by
the WBE program. Nonetheless, establishing this association
may be particularly helpful during early outbreaks of new diseases, before clinical testing is widely available, or during periods of low disease incidence, when rates of clinical testing
may wane.
Finally, some lessons from the development of NYC's
SARS-CoV-2 wastewater monitoring program may be useful
for agencies interested in implementing wastewater monitoring programs for emerging pathogens. First, collaborating
parties–including academic partners and NYC DEP personnel–worked in partnership to develop a monitoring program
centered around NYC DEP's priorities. Second, sample analysis was conducted in the NYC DEP microbiology laboratory,
which allowed the program to take advantage of existing
equipment, expertise, wastewater sampling and transport
protocols and infrastructure, and resources related to wastewater analysis, while maximizing use of the NYC DEP's extensive knowledge base and data. Doing so expedited the initiation of the wastewater monitoring program, allowed protocol
adjustments to respond to practical challenges as well as
technical ones, and supported a rich training experience, in
which analysts shared insights from hands-on experience,
contributed to workflow decisions, and were exposed to the
empirical reasoning behind methodological choices.
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